The board of directors of Shanghai Haohai Biological Technology Co., Ltd. proposed to appoint Mr. Tang Minjie as an executive director of the third session of the Board. The appointment of Mr. Tang as executive director is subject to approval of the shareholders of the company at its extraordinary general meeting. The Board announced that Mr. Tang has been appointed as the chief financial officer of the company with effect from 9 December 2016.

Mr. Tang, aged 41, joined the Company in August 2016 as an employee and became a director of Shenzhen New Industries Material of Ophthalmology Co., Ltd. a non-wholly owned subsidiary of the company, since 15 November 2016. Prior to joining the Company, he worked at Ernst and Young during the period from August 1998 to July 2016 and most recently served as an audit partner from July 2010 to July 2016.